Neurodegenerative pathways as targets for acquired epilepsy therapy development

Area of Science:

• Neuroscience
• Neurology
• Pathology

Background:

• Acquired epilepsy and neurodegenerative diseases share etiological mechanisms.
• Epilepsy is often underdiagnosed in neurodegenerative conditions like Alzheimer's disease.
• Acquired epilepsy can be progressive, leading to drug resistance and cognitive decline.

Purpose of the Study:

• To review neurodegenerative pathways as potential therapeutic targets for acquired epilepsy.
• To explore novel pharmacological therapies for acquired epilepsy and associated comorbidities.
• To examine evidence supporting disease-modifying treatments for acquired epilepsy.

Main Methods:

• Review of clinical and experimental evidence.
• Analysis of shared neurobiological pathways in neurodegeneration and epileptogenesis.
• Synthesis of published data on therapeutic targets and outcomes.

Main Results:

• Neurodegenerative pathways offer promising targets for anti-epileptogenic therapies.
• Targeting these pathways may modify epilepsy progression and reduce comorbidities.
• Evidence supports the potential for disease-modifying treatments.

Conclusions:

• Pharmacological targeting of neurodegenerative pathways holds promise for treating acquired epilepsy.
• Novel therapies could prevent epilepsy development or modify its progression.
• This approach may also mitigate neurocognitive and neuropsychiatric decline.